Minoxidil vs RU58841, Finasteride vs Dutasteride: What I’d Track Before Escalating
A practical, non-medical comparison of minoxidil vs RU58841 and finasteride vs dutasteride, with what to track before changing a hair-loss stack.
Not medical advice. This is a practical tracking guide from lived hair-loss experience, written for people who are comparing treatment stacks and trying not to make anxious changes too early. RU58841 is not an approved consumer medication. Finasteride, dutasteride, minoxidil, compounded topicals, and any off-label treatment decisions belong with a board-certified dermatologist.
The internet loves a stack war: minoxidil vs RU58841, finasteride vs dutasteride, oral vs topical, research chemical vs prescription, nuclear option vs “safe” option. I understand the pull because I have been the person reading those threads at midnight, trying to decide whether the next bottle, foam, tablet, or topical mix is finally the thing that will stop the corner recession and vertex panic. The problem is that most comparisons are written like shopping guides. Hair loss does not behave like shopping.
A hair-loss stack is not just a list of ingredients. It is a timeline. It is your baseline density, your shedding phase, your dose adherence, your scalp tolerance, your side-effect anxiety, your haircut, your lighting, your photos, and the six-month window you either respect or sabotage. Folicle exists because I wanted a way to measure that timeline instead of changing treatment every time the mirror scared me.
So this article compares two different questions. First: minoxidil vs RU58841, which is really growth stimulation and hair-cycle support versus androgen-receptor blockade in an experimental compound. Second: finasteride vs dutasteride, which is really type II 5-alpha-reductase inhibition versus broader type I and type II inhibition. They are not interchangeable, and they should not be judged with the same checklist.
Quick answer: these are not four versions of the same thing
Minoxidil is the most established topical growth treatment in this conversation. It does not solve the androgen signal directly, but it has human randomized-trial evidence, widely recognized labeling, and decades of real-world use. If someone is starting from zero, minoxidil is usually discussed as a growth-support tool, not as an anti-androgen.
RU58841, usually called RU, sits in a very different category. It is discussed online as a topical non-steroidal anti-androgen that binds androgen receptors locally, but it is not an approved hair-loss medication. The evidence people cite is mostly old preclinical or model-based work, not the kind of modern long-term human data you would want before putting something into a routine for years.
Finasteride and dutasteride are closer relatives. Both reduce DHT by inhibiting 5-alpha-reductase enzymes. Finasteride is the familiar 1 mg hair-loss drug in many markets. Dutasteride blocks type I and type II 5-alpha-reductase and tends to suppress DHT more strongly, but it is also longer acting and, depending on country, may be off-label for hair loss. That difference matters if you are thinking about side effects, washout, fertility planning, or just how reversible a decision feels.
The tracking question is not “which one sounds strongest?” It is “what exactly changed, when did it change, and do I have clean enough evidence to know?”
Minoxidil vs RU58841: growth support vs androgen-receptor blockade
Minoxidil and RU are often compared because both are topical in the way people talk about them, but their logic is different. Minoxidil is not trying to block DHT at the receptor. It is used to support hair growth and shift follicle cycling. RU is discussed as a local anti-androgen: the idea is that it competes at the androgen receptor so DHT and testosterone have less signaling power at the follicle.
That sounds elegant on paper, especially if you are the kind of person who keeps thinking, “What if DHT suppression is not enough because testosterone still binds the receptor?” The issue is not whether the theory is interesting. The issue is whether a normal person should treat online-source RU like a proven, quality-controlled, long-term treatment. That is where the evidence gap becomes huge.
Topical minoxidil has randomized human studies behind it. For example, a clinical trial comparing 5% topical minoxidil, 2% topical minoxidil, and placebo in men with androgenetic alopecia is indexed on PubMed. I would still track it carefully because response is slow and variable, but the evidence category is recognizable. See the 5% vs 2% minoxidil trial.
RU58841 has a different evidence profile. One frequently cited PubMed-indexed study looked at human balding scalp grafts maintained on testosterone-conditioned nude mice. That is interesting science, but it is not the same thing as a long-term, consumer-ready safety and efficacy dataset in people using internet-sourced RU on their scalps. See the RU58841 scalp graft study.
This is the main reason I would never frame RU as simply “stronger minoxidil.” It is not. Minoxidil and RU answer different biological questions, and one has a much more normal clinical evidence trail than the other. If someone is already under dermatology care and is asking about experimental anti-androgens, that is a medical conversation. If someone is browsing forums and mixing powders at home because a graph looked good, that is a risk conversation.
What I would track before adding RU to anything
Before even thinking about RU, I would want a boringly clean baseline. That means at least four to eight weeks of repeatable photos, not random bathroom shots. Same room, same light, same hair length if possible, same wet or dry state, same camera distance, same angles. You cannot evaluate a controversial add-on if your data is chaos.
I would also want to know whether the current stack is actually failing. A lot of people escalate because they hit a shed, not because the treatment failed. Minoxidil can cause early shedding. Seasonal shedding can happen. Haircuts change the appearance of density. Crown photos look brutal under direct overhead light. If you add RU during a noisy phase, every later change becomes impossible to attribute.
The practical checklist is simple: log the exact routine, log missed applications, track scalp irritation, take weekly photos, and mark any change in shampoo, microneedling, diet, sleep, stress, or haircut. If the only record says “started RU sometime in March, hair looks worse now,” that record is not strong enough to teach you anything.
This is where a tool like Folicle helps because the goal is not to sell you on a treatment. The goal is to keep the comparison honest across months. If you are judging a topical routine, start with the photo setup first. Read the hair photo alignment guide.
Finasteride vs dutasteride: same family, different force
Finasteride and dutasteride are easier to compare because they live in the same pharmacological neighborhood. Both are 5-alpha-reductase inhibitors. Both reduce the conversion of testosterone to DHT. Both are discussed constantly in male pattern hair-loss communities. The big difference is breadth and intensity.
Finasteride is usually described as primarily inhibiting type II 5-alpha-reductase. Dutasteride inhibits type I and type II. That broader inhibition is why dutasteride often looks stronger in hair-count comparisons. But stronger is not automatically better for every person. A stronger and longer-acting drug can also feel more intimidating if you are prone to side-effect anxiety or if you want changes to be easier to reverse.
A PubMed-indexed randomized study in men with androgenetic alopecia compared different dutasteride doses, finasteride 1 mg, and placebo over 24 weeks. Dutasteride 0.5 mg performed strongly on hair-count and photographic outcomes compared with finasteride and placebo in that trial. See the dutasteride vs finasteride randomized study.
A later systematic review and meta-analysis also reported better efficacy signals for dutasteride compared with finasteride across several outcomes, while noting the trial evidence base. See the dutasteride vs finasteride meta-analysis.
That does not mean everyone should jump from finasteride to dutasteride. It means the “dutasteride is stronger” claim has more support than many online claims do. The next question is whether the person has given finasteride enough time, whether the loss is still progressing in clean photos, whether side effects are present, and whether a dermatologist agrees the risk-benefit tradeoff makes sense.
The side-effect conversation should be tracked, not hand-waved
Hair-loss forums swing between two bad extremes. One side acts like every side effect story is fake fearmongering. The other side acts like every tablet is guaranteed disaster. Neither posture helps when you are the person actually deciding what to put in your body.
The more useful approach is boring and documented. Systematic reviews have examined sexual adverse effects and safety questions around finasteride and dutasteride. The details vary by study design and population, but the takeaway for a normal user is not “ignore it.” The takeaway is “track it honestly and talk to a clinician.” See a systematic review on 5-alpha-reductase inhibitor safety.
If I were tracking finasteride or dutasteride now, I would log libido, erectile function, mood, sleep, anxiety, breast tenderness, testicular discomfort, scalp itch, and any other symptom that feels meaningfully different. I would not obsess over the log five times a day. I would review it weekly, alongside photos and adherence. Side-effect tracking should reduce confusion, not become a new form of doomscrolling.
This is especially important with dutasteride because of its long half-life. If someone feels uncertain or anxious, a longer-acting drug can be psychologically harder to trial. That does not make dutasteride bad; it makes the decision more serious. The stronger the lever, the more you want medical guidance and cleaner records.
Where minoxidil fits if you are already using a 5-ARI
Minoxidil and a 5-alpha-reductase inhibitor are often combined because they target different parts of the problem. The simplified model is that finasteride or dutasteride reduces androgen-driven miniaturization pressure, while minoxidil supports growth cycling and visible regrowth potential. That is why so many routines include both.
The tracking trap is that adding both at once makes attribution hard. If you start minoxidil and finasteride on the same day and see shedding at week six, which one caused it? If you improve at month six, which one helped most? In real life you may not care as long as hair improves, but if side effects or irritation appear, attribution suddenly matters.
For minoxidil specifically, I would track the 4-to-6-month window with photos before declaring victory or failure. Early shedding can scare people into stopping too soon. A structured timeline helps. Read the minoxidil before-and-after tracking guide.
If you are already on finasteride and considering dutasteride, I would avoid changing minoxidil, shampoo, microneedling depth, and oral supplements in the same month if possible. The internet calls that optimization. Your future self may call it impossible to interpret.
The “RU because fin/dut do not block testosterone” argument
One of the more viral RU arguments goes like this: finasteride and dutasteride reduce DHT, but they do not stop testosterone itself from binding the androgen receptor, so you need a topical androgen-receptor blocker. Mechanistically, this is why RU fascinates people. It seems to attack the problem downstream of DHT synthesis.
The catch is that a good mechanistic story is not the same as a safe consumer product. Many failed or abandoned compounds had beautiful mechanisms. For RU, the missing pieces are exactly the pieces a cautious person should care about: standardized product quality, approved labeling, large human trials, long-term adverse-event tracking, and clinician-supervised use.
If you are reading this because RU feels like the secret upgrade nobody wants to talk about, I would slow down. The fact that something is discussed on forums does not make it equivalent to approved minoxidil or prescribed 5-alpha-reductase inhibitors. A forum stack can be interesting; your scalp and endocrine system are not a comment section.
My practical hierarchy before changing a stack
If I were rebuilding from zero, I would not start with “what is the strongest stack?” I would start with “what can I measure for six months without losing my mind?” The best stack on paper is useless if you quit in week eight because the photos are inconsistent and every shed feels like failure.
First, I would create a baseline. Five angles, weekly cadence, stable lighting, and written notes. Second, I would choose the simplest medically reasonable routine with a dermatologist. Third, I would avoid adding multiple new variables at once. Fourth, I would predefine what I am looking for at 90 days and 180 days: shedding trend, hairline stability, crown coverage, density score, side effects, and adherence.
Folicle is built around that hierarchy. It does not diagnose, prescribe, or tell you to take RU, finasteride, dutasteride, or minoxidil. It gives you the measurement layer: aligned photos, treatment notes, Hair Score, and PDF export. See how Folicle compares with treatment providers.
How to compare outcomes without lying to yourself
Do not compare a wet hair photo to a dry hair photo. Do not compare a harsh downlight crown shot to a soft window-light crown shot. Do not compare fresh haircut density to long, oily, separated hair. Do not take the best photo from month one and the worst photo from month three. That is not tracking; that is self-torture with a camera.
For hairline, use the same facial expression and angle. For temples, pull hair back with the same tension. For crown, use the same overhead setup. For diffuse thinning, part the hair the same way. If you use fibers, wash them out before tracking. If you dermaroll or microneedle, do not take the comparison photo right after redness. If you change hair length, mark it in the log.
When comparing treatments, the best metric is rarely one dramatic before-and-after. It is a pattern across multiple controlled images. If the hairline is stable, the crown is slightly denser, and shedding is lower across several weeks, that tells a different story than one viral photo under perfect lighting.
For people using visual scales, the Norwood and Ludwig pages can also help name the pattern before judging treatment. Open the Folicle hair-loss tools hub.
My verdict: minoxidil vs RU, finasteride vs dutasteride
Minoxidil vs RU is not a normal “which is better?” comparison. Minoxidil is established, approved in many markets, and supported by human clinical data. RU is experimental, not approved, and surrounded by product-quality and long-term safety questions. I would treat RU as a medical-risk conversation, not as a casual topical upgrade.
Finasteride vs dutasteride is a more legitimate clinical comparison. Dutasteride often looks stronger in studies, especially at 0.5 mg, because it inhibits more 5-alpha-reductase activity. Finasteride is more familiar in hair-loss prescribing and may feel like a more conservative first systemic step for many people. The right answer depends on risk tolerance, medical history, country, fertility plans, side effects, and clinician guidance.
The most honest answer is that treatment strength is only one variable. Consistency, time, tolerability, adherence, and clean photos decide whether you can actually learn from the stack. If you keep escalating without measurement, you may end up with a more complicated routine and no better idea what is working.
A 180-day tracking template
Day 0: capture baseline photos and write the exact routine. Include product names, concentrations, dose timing, frequency, and any pre-existing symptoms. If you are anxious about side effects, write the baseline before starting so you are not guessing later.
Weeks 1 to 4: track adherence and irritation. Do not judge regrowth. If shedding starts, record it without panicking. Take the same weekly photos. Avoid adding a second new treatment unless a clinician tells you otherwise.
Weeks 5 to 12: watch for shedding patterns, tolerance, and whether you are staying consistent. If you started minoxidil, this window can be psychologically difficult because shedding can overlap with treatment anxiety. If you started a 5-ARI, this is still early for visible cosmetic judgment.
Months 4 to 6: this is where photos become more useful. Compare controlled images, not memory. Look at hairline, crown, mid-scalp, and part line separately. If you are worse, better, or unchanged, bring the photo record to your dermatologist before making a big escalation.
The point is not to be passive for six months. The point is to be deliberate. You can still message a clinician, stop a treatment because of side effects, or change a plan when needed. The difference is that your decisions come from evidence instead of a bad mirror day.
References
These references are included for context, not as personal medical advice. Always ask a qualified clinician before starting, stopping, or switching prescription or experimental treatments.
A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in men
A multicenter randomized trial of 5% minoxidil topical foam versus placebo
Efficacy and safety of 10% topical minoxidil versus 5% topical minoxidil and placebo
RU58841 on human balding scalp grafts in testosterone-conditioned nude mice
A randomized study of dutasteride doses versus placebo and finasteride in male androgenetic alopecia
Finasteride increases anagen hair in men with androgenetic alopecia
Adverse effects and safety of 5-alpha reductase inhibitors: systematic review
Frequently asked questions
Is RU58841 safer than finasteride or dutasteride?
No one can honestly say that from the public evidence. RU58841 is not an approved hair-loss medication, and long-term human safety data are not comparable to approved or commonly prescribed treatments. Discuss it with a dermatologist rather than treating forum anecdotes as safety data.
Is minoxidil better than RU58841?
They are not directly equivalent. Minoxidil is an established growth-support treatment with human trial evidence. RU58841 is discussed as a topical androgen-receptor antagonist but remains experimental and unapproved for consumer hair-loss treatment.
Is dutasteride stronger than finasteride for hair loss?
Many studies and meta-analyses suggest dutasteride, especially 0.5 mg, can produce stronger hair-count outcomes than finasteride 1 mg in men with androgenetic alopecia. Stronger does not automatically mean right for everyone, because side effects, half-life, medical history, and clinician guidance matter.
Should I switch from finasteride to dutasteride?
That is a medical decision. Before switching, track whether finasteride has had enough time, whether photos show true progression, whether side effects exist, and whether your dermatologist agrees the risk-benefit tradeoff makes sense.
Can I use minoxidil with finasteride or dutasteride?
Many people use minoxidil with a 5-alpha-reductase inhibitor because they target different mechanisms. The practical challenge is attribution: if you start several treatments at once, it becomes harder to know what helped or caused side effects.
How long should I track before judging minoxidil?
A 4-to-6-month window is more useful than a few weeks, unless side effects or irritation require earlier medical attention. Weekly aligned photos make the timeline easier to interpret.
Why is RU58841 so popular online?
The theory is attractive: block androgen signaling at the receptor level rather than only reducing DHT. But an attractive mechanism is not the same as an approved, standardized, long-term safety-tested treatment.
What should I track if I change my hair-loss stack?
Track weekly photos, exact products and doses, missed applications, shedding, scalp irritation, libido, mood, sleep, haircut changes, and any symptom you would want a dermatologist to know.
Does Folicle recommend RU, finasteride, dutasteride, or minoxidil?
No. Folicle is a measurement tool. It helps you capture aligned photos, treatment notes, Hair Score trends, and exportable history so medical decisions can happen with better evidence.
What is the safest way to compare treatment results?
Use the same photo setup every week, avoid changing several variables at once, define a 90-to-180-day review window, and bring the record to a qualified dermatologist before making major changes.
Can RU58841 replace finasteride or dutasteride?
I would not treat RU58841 as a direct replacement. Finasteride and dutasteride have a clearer clinical evidence base. RU is experimental and unapproved, so replacing a prescribed plan with RU should be discussed with a dermatologist, not copied from a forum thread.
Why do some people stack minoxidil, finasteride, and RU together?
The theory is that each targets a different layer: minoxidil supports growth cycling, finasteride reduces DHT, and RU is discussed as receptor-level blockade. The problem is attribution and safety. If several variables change at once, it becomes harder to know what helped or harmed.
Does a higher minoxidil percentage mean better results?
Not automatically. Higher concentrations may increase irritation or side effects and do not guarantee a better cosmetic result. If you change concentration, track scalp tolerance, shedding, adherence, and photos instead of assuming stronger equals better.
Is oral minoxidil better than topical minoxidil?
Oral minoxidil is a medical decision because it can have systemic cardiovascular effects. Some studies discuss oral dosing, but that does not make it a casual upgrade. Talk to a clinician and track blood pressure or symptoms if prescribed.
How long should I wait before switching from finasteride to dutasteride?
There is no universal timeline. Many people need several months of consistent treatment before judging. If photos still show progression after an adequate trial, bring the timeline to a dermatologist and discuss whether dutasteride makes sense.
What if I shed after starting minoxidil or changing my stack?
Shedding can happen for multiple reasons, including treatment changes, seasonal shedding, stress, or progression. Do not judge from one week. Track the start date, severity, photos, adherence, and scalp irritation, then review the trend with a clinician if it continues.
Is topical finasteride safer than oral finasteride?
Topical finasteride may reduce systemic exposure for some users, but it is not automatically side-effect-free. Concentration, dose, vehicle, application area, and absorption matter. Treat it as a real medication and discuss it with a clinician.
Is topical dutasteride the same as oral dutasteride?
No. Route, absorption, formulation, dose, and evidence base differ. Topical dutasteride is often discussed online, but you should not assume it has the same risk or benefit profile as prescribed oral dutasteride.
Can Folicle tell which treatment caused regrowth?
Folicle can make attribution easier by keeping photos and treatment notes in one timeline, but it cannot prove causation. If you start three treatments at once and improve, the app can show the trend, not isolate the exact ingredient responsible.
How should I track if I plan a hair transplant later?
Track density, crown coverage, donor-area notes, medication consistency, and shedding for several months before consultations. A clean timeline can help your surgeon understand stabilization, but transplant planning still belongs with qualified clinicians.